PSMA3 and Miyoshi myopathy: Xu et al. reported that the bone marrow (BM)-MSC-Exo-associated activation of the PSMA3-AS1-PSMA3 pathway plays a role in the MM cells’ resistance to the proteasome inhibitor [53].